Abbott advances two pulsed field ablation studies for AFib treatment

Abbott advances two pulsed field ablation studies for AFib treatment

Abbott achieved key milestones in trials for their pulsed field ablation (PFA) technology, with positive results in VOLT-AF study for atrial fibrillation. The innovative VOLT PFA system offers improved catheter contact and stability, showing promise for AF treatment.

Read More

Did you find this insightful?